<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Cirrhosis • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Cirrhosis • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/cirrhosis/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/cirrhosis/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="cirrhosis" tabindex="-1">cirrhosis</h1>
<ul>
<li>related: <a href="/wiki/notes/GI/">GI</a></li>
<li>tags: #note</li>
</ul>
<hr>
<h2 id="things-to-know-for-cirrhosis-patients" tabindex="-1">Things to know for cirrhosis patients</h2>
<ul>
<li>BM per day: lactulose or rifaximin</li>
<li>Volume status: on lasix and aldactone</li>
<li>Last endoscopy: any varices</li>
<li>Last cancer screening: US/CT/AFP</li>
<li>Transplant?</li>
<li>Hx of SBP</li>
<li>TIPS procedures?</li>
</ul>
<h2 id="ascites%3F-gi-bleed" tabindex="-1">Ascites? GI bleed</h2>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220808182936.png" alt=""></p>
<p>Patients without symptom improvement and serum sodium &gt; 120 mEq/L require combination oral high-dose spironolactone and low-dose furosemide to reduce fluid retention and avoid hyperkalemia.  Diuretics are titrated until symptoms improve.  Spironolactone is used as a single agent in patients with profound hypokalemia.  <mark>Intravenous furosemide should be avoided</mark> due to the risk of acute prerenal azotemia, which could be confused with hepatorenal syndrome.  Patients with refractory ascites require large-volume paracentesis, midodrine, transjugular intrahepatic portosystemic stent-shunt (TIPS), or liver transplant depending on response.</p>
<p>Fluid restriction can help patients with serum sodium &lt; 120 mEq/L.  NSAIDs, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers should be avoided in cirrhotics as they can reduce glomerular filtration rate and precipitate renal failure.</p>
<p>Referral for liver transplant evaluation should be considered at every visit.  Referral requires patient abstinence from alcohol and drugs for about 6 months and enrollment in an alcohol rehabilitation program.</p>
<p>Therapeutic paracentesis is usually indicated to reduce intra-abdominal pressure in symptomatic patients (eg, shortness of breath, abdominal pain, and early satiety).  It is also used to treat some patients with ascites refractory to initial diuretic therapy.</p>
<ul>
<li>spirnolactone: 100, lasix 40 go up to aldactone 400, lasix 160, increase every 3-5 days</li>
</ul>
<h2 id="egd" tabindex="-1">EGD</h2>
<p>This patient's presentation - newly developed ascites, serum albumin-ascites gradient (SAAG) &gt;1.1, thrombocytopenia, elevated INR, and splenomegaly - is consistent with <strong>decompensated cirrhosis</strong>, likely due to nonalcoholic steatohepatitis.  Current guidelines recommend a screening <strong>upper endoscopy</strong> (eg, esophagogastroduodenoscopy [EGD]) in patients with cirrhosis at the time of diagnosis to document the presence of <strong>varices</strong>.</p>
<p>Indications for prophylaxis to reduce risk of hemorrhage in patients with documented varices are based on varix size, presence of decompensated cirrhosis, and signs indicating high-bleed risk (Table).  Nonselective beta blockers (eg, propanolol, nadolol) are typically first-line agents for those who require prophylaxis, with endoscopic variceal ligation (EVL) generally reserved for patients with large varices or who cannot tolerate medications.  Patients who undergo EVL require repeat EGD every few weeks until varices are obliterated.</p>
<p>Beta blockers do not prevent the formation of varices, are not recommended in patients without varices, and should not be started prior to EGD <strong>(Choice B)</strong></p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        <nav class="toc" >
        <ul><li><a href="#things-to-know-for-cirrhosis-patients">Things to know for cirrhosis patients</a></li><li><a href="#ascites%3F-gi-bleed">Ascites? GI bleed</a></li><li><a href="#egd">EGD</a></li></ul>
      </nav>
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/GI/" class="peer">GI</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="gi" tabindex="-1">GI</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/Disorders%20of%20the%20Esophagus/">Disorders of the Esophagus</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Stomach%20and%20Duodenum/">Disorders of the Stomach and Duodenum</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Pancreas/">Disorders of the Pancreas</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Small%20and%20Large%20Bowel/">Disorders of the Small and Large Bowel</a></li>
<li><a href="/wiki/notes/Colorectal%20Neoplasia/">Colorectal Neoplasia</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Liver/">Disorders of the Liver</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Gallbladder%20and%20Bile%20Ducts/">Disorders of the Gallbladder and Bile Ducts</a></li>
<li><a href="/wiki/notes/Gastrointestinal%20Bleeding/">Gastrointestinal Bleeding</a></li>
</ul>
<h2 id="upper-gi" tabindex="-1">Upper GI</h2>
<ul>
<li><a href="/wiki/notes/Esophagitis/">Esophagitis</a></li>
<li><a href="/wiki/notes/Pernicious%20Anemia/">Pernicious Anemia</a></li>
<li><a href="/wiki/notes/sharp%20object%20ingestion/">sharp object ingestion</a></li>
<li><a href="/wiki/notes/celiac%20trunk%20blood%20supplies/">celiac trunk blood supplies</a></li>
<li>[[perforate</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
